IGIman K. Abdel Gadir

Iman K. Abdel Gadir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iman K. Abdel Gadir has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A comparative study of the antidiabetic and cardiopulmonary protective effects of Moringa oleifera and liraglutide in a rat model of alloxan-induced diabetes

    by Amal Naif Alshammari, Iman K. Abdel Gadir, Amal A. Abdulbaqi, Hind A.M Elamin, Eltuhami A. Abdalgadir, Hebatollah E. Eitah, Mohsen A. Khormi, Rabab A. Hegazy, Sultanah N. Alshammery

    Diabetes mellitus is one of the biggest health problems in the world, increasingly linked to complications in multiple organs, including significant cardiopulmonary dysfunction. Agonists of the glucagon-like peptide-1 (GLP-1) receptor provide efficient glycemic control; however, their accessibility remains limited in low-resource settings. A polyphenol-rich medicinal plant, Moringa oleifera , has shown promising antidiabetic and antioxidant properties, yet its comparative efficacy against certain therapies remains underexplored. This study was designed to assess the antidiabetic, antioxidant, and cardiopulmonary protective impact of M. oleifera extract in an alloxan-induced diabetic rat model, compared with liraglutide, a standard GLP-1 receptor agonist. Four groups of adult Wistar rats were allocated: normal control, diabetic controls receiving no treatment, diabetic rats treated with alcoholic extract of M. oleifera , and diabetic-induced group treated with liraglutide. Alloxan injection was used to induce diabetes. Biochemical markers of glucose homeostasis, oxidative stress, lipid profile, inflammation, and cardiac injury were assessed alongside histopathological evaluations of heart and lung tissues. Anti-apoptotic Bcl-2 and Bax gene expressions were also detected. Compared with untreated diabetic controls, both M. oleifera and liraglutide significantly improved glucose homeostasis markers in the treated rats. M. oleifera extract reduced fasting blood glucose to a level comparable to that achieved with liraglutide (76.74% vs. 77.96%, respectively). Dyslipidemia associated with alloxan-induced diabetes was normalized after both treatments. Moreover, markers of oxidative stress (malondialdehyde (MDA), and 8-hydroxy-2’-deoxyguanosine (8-OHdG) were markedly decreased. Both treatments enhanced antioxidant enzymes (catalase, glutathione peroxidase (GSHPx), and superoxide dismutase (SOD) and downregulated inflammatory and apoptotic mediators (myeloperoxidase (MPO), Bax, and Bcl2 genes. Following Moringa or liraglutide administration, preservation of cardiac and pulmonary tissue architecture was evidenced by a significant decrease in the cardiopulmonary injury biomarkers (troponin I, heart-type fatty acid binding protein (H-FABP), copeptin) and histological analysis. Although liraglutide exhibited marginally superior efficacy in some measures, most cardiopulmonary outcomes showed no significant difference between the two treatments. M. oleifera demonstrated strong cardiopulmonary protective effects in diabetic rats, mediated through its antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. Its effectiveness, oral bioavailability, and safety profile make it a promising supplemental treatment for diabetes-related cardiopulmonary complications, especially in settings with limited resources. Further clinical research is recommended to support our findings in human populations. GRAPHICAL Icons from www.flaticon.com :

  • Open Access

    Dual therapeutic potential of ethanolic plant extracts in diabetes and liver cancer: Comparative study with liraglutide and doxorubicin

    by Mohsen A. Khormi, Amal Naif Alshammari, Rabab A. Hegazy, Amani Alhejely, Eltuhami A. Abdalgadir, Iman K. Abdel Gadir, Hebatollah E. Eitah, Mohammed A. El-Magd, Sultanah Alshammery, Amal A. Abdulbaqi

  • Open Access

    Antimicrobial Potential of Some Medicinal Plants in Saudi Arabia and Jazan Region

    by Iman Abdel Gadir, Eltuhami Abdalgadir, Ahmed Eesa El-Shabasy

    Because of its climate diversity, the Kingdom of Saudi Arabia (KSA) has a very diverse range of plants many are traditionally used for the treatment of some infections. Current Knowledge of many Saudi medicinal plants that are useful in preventing infections by pharmacological means is presented in this study. For all information, the databases of Science Direct, Scopus, PubMed, Elsevier, Springer, and relevant research publications were consulted. It demonstrates the effective plant part with its family, the solvents used for extraction, the tested pathogenic microbes, and the antimicrobial effect indicated by inhibition zones and/or minimum inhibitory concentrations. This review highlights the significance of ethnobotanical uses of medicinal plants against various pathogens. The study reported a total of 79 medicinal plant species belonging to 26 families of which 90% are Dicot and 10% are Monocot. Most of the reported medicinal species (13%) belong to Asteraceae. Among studied bacterial pathogens, the majority of the documented ethnobotanical research focused on the effects of different plant extracts against Staphylococcus aureus (30%) while Candida albicans represented the most studied fungi (69%). Data analysis was conducted to show how to use these results in the future, however, more investigation is still required to confirm the safety and therapeutic use of many of these plants using phytochemical and toxicological analyses.


  • Open Access

    GC‐MS Profiling and Therapeutic Potentials of Prosopis juliflora (Sw.) DC: Cytotoxic and Antimicrobial Insights

    by Asaad Khalid, Eltuhami A. Abdalgadir, Iman K. Abdel Gadir, Ashraf N. Abdalla, Husham E. Homeida, Shahnaz Sultana, Zia Ur Rehman, Rym Hassani, Ahmed Shaher Alqahtani, Hassan A. Alhazmi

    Plants belonging to the genus Prosopis L. (family Fabaceae, subfamily Mimosoideae) have gained significant popularity in traditional medicine due to their potential as anticancer, antidiabetic, anti‐inflammatory, and antibacterial compounds. The primary objective of this work was to determine the phytochemical composition of the ethanolic extract derived from Prosopis juliflora leaves, as well as to assess its antibacterial and cytotoxic properties. The phytochemical screening using GC‐MS revealed the presence of phytosteroids, ketone, esters, diisooctyl phthalate, and triterpenes. Besides, varying amounts of some silicon derivatives, which were reported to have antimicrobial activity, were detected with octasiloxane, which showed the highest amount (18.47%). 6‐Ethoxy‐6‐methyl‐2‐cyclohexenone (antioxidant, antidiabetic, antiobesity, and antimicrobial) was detected in considerable quantity. Cytotoxic activity was seen in human breast cancer (MCF‐7), human ovary adenocarcinoma (A2780), and human colon adenocarcinoma (HT‐29) cell lines, as well as in normal human fetal lung fibroblasts (MRC‐5), when subjected to the MTT assay. The plant extract exhibited the highest level of activity (5.75 μg/mL) against the A2780 cell line, with the MCF‐7 cell line showing a somewhat lower level of activity (18.49 μg/mL). The antibacterial effect of the plant extracts was evaluated against four standard Gram‐positive and four standard Gram‐negative. The antimicrobial potential was observed only against Staphylococcus aureus which recorded a 14.5 ± 0.05 mm inhibition zone. The present study has demonstrated the identification of bioactive constituents in P. juliflora plant extracts, which exhibit significant cytotoxic activity against breast and colon malignancies. The study also highlighted P. juliflora extract as an antibacterial against S. aureus.